Cortexyme (CRTX) Stock Chart & Stock Price History → America’s worst nightmare? (From Porter & Company) (Ad) Free CRTX Stock Alerts $0.92 -0.03 (-3.16%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsInsider TradesSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSocial Media Cortexyme Stock Price Performance5 Day Performance-3.19%1 Month Performance-8.49%3 Month Performance-29.25%6 Month Performance+2.48%Year-To-Date Performance-12.41%1 Year Performance-40.28% Receive CRTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cortexyme and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyTruth about Trump you’ve never heardEverything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. For the full story, click here. CRTX Stock Chart for Wednesday, May, 15, 2024 CRTX Chart by TradingView Cortexyme Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$0.92$0.92$0.95$0.9059,201 shs$27.73 million05/13/2024$0.95$0.92-3.19%$0.95$0.9059,191 shs$27.73 million05/10/2024$0.91$0.95+4.40%$0.96$0.90134,198 shs$28.64 million05/09/2024$0.91$0.91$0.93$0.90169,176 shs$27.44 million05/08/2024$0.92$0.91-1.09%$0.93$0.90168,976 shs$27.44 million05/07/2024$0.99$0.92-6.61%$0.99$0.90193,863 shs$27.74 million Get the Latest News and Ratings for CRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cortexyme and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$0.99$0.99$0.99$0.9249,304 shs$29.70 million05/03/2024$0.96$0.96$1.07$0.93105,089 shs$28.95 million05/02/2024$1.07$0.96-10.28%$1.07$0.93104,589 shs$28.95 million05/01/2024$1.06$1.07+1.42%$1.12$1.0596,568 shs$32.26 million04/30/2024$1.06$1.06$1.10$1.0525,698 shs$58.79 million04/29/2024$1.06$1.06-0.47%$1.10$1.0525,698 shs$31.81 million04/26/2024$1.06$1.03-2.83%$1.08$1.0393,060 shs$31.06 million04/25/2024$1.11$1.06-4.50%$1.12$1.0591,171 shs$31.96 million04/24/2024$1.06$1.11+4.72%$1.11$1.04129,361 shs$33.47 million04/23/2024$1.05$1.06+0.95%$1.10$1.0057,652 shs$31.96 million04/22/2024$1.05$1.05$1.07$1.0297,247 shs$31.66 million04/19/2024$1.06$1.05-0.94%$1.07$1.0297,247 shs$31.66 million04/18/2024$1.00$1.06+6.00%$1.07$0.9880,573 shs$31.96 million04/17/2024$1.01$1.00-0.50%$1.02$0.96107,929 shs$30.15 million04/16/2024$1.01$1.01$1.05$0.9576,138 shs$30.30 million04/15/2024$0.94$1.01+6.59%$1.05$0.9576,138 shs$30.30 million04/12/2024$1.00$1.00$1.07$0.9774,829 shs$30.15 million04/11/2024$0.99$1.00+1.01%$1.07$0.9774,828 shs$30.15 million04/10/2024$1.04$0.99-4.81%$1.05$0.9984,422 shs$29.85 million04/09/2024$1.95$1.04-46.67%$1.05$1.0118,739 shs$31.36 million04/08/2024$1.03$1.95+90.24%$1.97$1.86272,200 shs$58.79 million04/05/2024$1.04$1.04$1.04$1.0144,995 shs$31.36 million04/04/2024$1.05$1.04-0.95%$1.04$1.0144,995 shs$31.36 million04/03/2024$1.09$1.05-3.67%$1.11$1.0351,435 shs$31.66 million04/02/2024$1.06$1.09+2.83%$1.14$1.05109,138 shs$32.87 million04/01/2024$1.06$1.06$1.13$1.0551,834 shs$31.96 million03/29/2024$1.06$1.06$1.13$1.0551,834 shs$31.96 million03/28/2024$1.13$1.06-6.19%$1.13$1.0551,744 shs$31.96 million03/27/2024$1.13$1.13$1.25$1.1267,069 shs$34.07 million03/26/2024$1.20$1.13-5.83%$1.25$1.1266,905 shs$34.07 million03/25/2024$1.20$1.20$1.22$1.1816,300 shs$36.18 million03/22/2024$1.17$1.20+2.56%$1.22$1.1816,298 shs$36.18 million03/21/2024$1.21$1.17-3.31%$1.23$1.1437,737 shs$35.28 million03/20/2024$1.19$1.21+1.68%$1.23$1.1636,418 shs$36.48 millionElon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.03/19/2024$1.19$1.19$1.25$1.1459,267 shs$35.88 million03/18/2024$1.16$1.19+2.59%$1.25$1.1459,214 shs$35.88 million03/15/2024$1.18$1.16-1.69%$1.23$1.1422,862 shs$34.98 million03/14/2024$1.18$1.18$1.25$1.1558,807 shs$35.58 million03/13/2024$1.20$1.18-1.67%$1.25$1.1558,807 shs$35.58 million03/12/2024$1.17$1.20+3.00%$1.25$1.1764,824 shs$36.18 million03/11/2024$1.17$1.17$1.23$1.0862,843 shs$35.13 million03/08/2024$1.17$1.16-0.85%$1.25$1.1440,440 shs$34.98 million03/07/2024$1.21$1.17-3.31%$1.27$1.1618,544 shs$35.28 million03/06/2024$1.21$1.21$1.22$1.1627,137 shs$36.48 million03/05/2024$1.28$1.21-5.47%$1.22$1.1627,090 shs$36.48 million03/04/2024$1.28$1.28$1.33$1.2593,596 shs$38.59 million03/01/2024$1.34$1.30-2.99%$1.37$1.3057,121 shs$39.20 million02/29/2024$1.34$1.34$1.40$1.31164,572 shs$40.40 million02/28/2024$1.29$1.34+3.88%$1.40$1.31164,571 shs$40.40 million02/27/2024$1.33$1.29-3.01%$1.42$1.28118,588 shs$38.90 million02/26/2024$1.33$1.33$1.36$1.2736,077 shs$40.10 million02/23/2024$1.30$1.33+2.31%$1.36$1.2736,026 shs$40.10 million02/22/2024$1.35$1.30-3.70%$1.36$1.3022,649 shs$39.20 million02/21/2024$1.28$1.35+5.47%$1.41$1.27109,330 shs$40.70 million02/20/2024$1.28$1.28$1.32$1.2374,289 shs$38.59 million02/19/2024$1.28$1.28$1.32$1.2374,289 shs$38.59 million02/16/2024$1.30$1.28-1.54%$1.32$1.2374,289 shs$38.59 million02/15/2024$1.19$1.30+9.24%$1.34$1.28100,322 shs$39.20 million02/14/2024$1.30$1.19-8.46%$1.30$1.1945,192 shs$35.88 million Related Companies: NKGen Biotech Stock Price Chart ZIVO Bioscience Stock Price Chart Surrozen Stock Price Chart Brainstorm Cell Therapeutics Stock Price Chart Evaxion Biotech A/S Stock Price Chart Pluri Stock Price Chart Aptose Biosciences Stock Price Chart AIM ImmunoTech Stock Price Chart Achilles Therapeutics Stock Price Chart SAB Biotherapeutics Stock Price Chart Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cortexyme and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRTX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cortexyme, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.